|Bid||2.82 x 900|
|Ask||3.98 x 1000|
|Day's Range||3.8200 - 4.0400|
|52 Week Range||3.3900 - 4.1100|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Dawson James Securities, Inc. in conjunction with IMAC Holdings, Inc. (IMAC) announced today the closing of its firm commitment underwritten Initial Public Offering of 850,000 Units, with each unit consisting of one share of common stock and two warrants to purchase one share of common stock, at a combined price of $5.125 per unit. The exercise price of the warrants is $5.00 per warrant and expire in February 2024. The units separated immediately and trade under the respective NASDAQ ticker symbols of IMAC and IMACW. A registration statement on Form S-1 relating to this offering was filed with the Securities and Exchange Commission (“SEC”) and was declared effective by the SEC on February 12, 2019.
IMAC Holdings Inc. is offering 850,000 shares at $5 per share on the The Nasdaq Capital Market in an effort to raise $4.25 million.
IMAC Holdings, Inc. (IMAC), a provider of regenerative rehabilitation orthopedic treatments without the use of surgery or opioids, announced today the pricing of its firm commitment underwritten initial public offering of 850,000 units, with each unit consisting one share of common stock and two warrants each to purchase one share of common stock, at a combined initial public offering price of $5.125 per unit. The exercise price of the warrants is $5.00 per warrant. The units will immediately and automatically separate upon issuance, and the common stock and warrants will begin trading today on The NASDAQ Capital Market under the ticker symbols “IMAC” and “IMACW,” respectively. The Company expects to receive aggregate gross proceeds of $4,356,250 from this offering, before deducting underwriting discounts, commissions and other related expenses.